Scientists have successfully transplanted laboratory-grown human brain tissue into genetically engineered mice, marking a significant step forward in the study of human brain development and disease. This breakthrough may accelerate research into neurological disorders such as autism, epilepsy, cerebral palsy, and schizophrenia.
The research team cultivated three-dimensional human cortical organoids—miniature, simplified versions of brain tissue designed to replicate key features of the cerebral cortex—and implanted them into mice engineered to lack most of their own cerebral cortex and hippocampus. The cerebral cortex is responsible for higher cognitive functions including language, attention, and decision-making, while the hippocampus is crucial for memory formation.
By genetically modifying mice to prevent the development of these brain regions, scientists created space for the human organoids to grow and integrate into the mouse nervous system. The transplanted tissue developed a wide range of cortical cell types, including the rare von Economo neurons, which are implicated in some forms of dementia. These human cells formed functional connections within the mouse brain, allowing researchers to observe neural network formation and activity.
“This model allows us to investigate human neural tissue across multiple levels—from genetic and cellular processes to neural circuits and behavioral outcomes,” said Sergiu Pasca, a neuroscientist at Stanford University and senior author of the study published on September 16 in the journal Nature. Pasca emphasized that the resulting animals, which the researchers term “xenocortical mice” due to their incorporation of foreign human tissue, retain their mouse nervous systems rather than possessing “humanized” or “mini-brain” characteristics.
The study further demonstrated the model’s utility by exposing these mice to oxygen deprivation during early development, a condition known to cause brain injuries in humans that can lead to disorders such as cerebral palsy and increase risks of autism and epilepsy. Unlike normal laboratory mice, the xenocortical mice exhibited significant damage to the human cortical cells after oxygen deprivation, accompanied by impairments in gait and motor coordination.
Pasca highlighted the ethical considerations of the research, noting strict adherence to animal welfare guidelines to minimize suffering and justify the use of genetically modified animals. He also acknowledged concerns regarding the possible emergence of novel neural functions from the integration of human brain tissue, underscoring ongoing ethical evaluation.
While the bioengineered mice appeared typical in their behavior, subtle deficits in fine motor skills and memory were observed. Pasca noted the importance of advancing this research, given the prevalence of brain disorders affecting nearly one in five individuals worldwide and the limited understanding and treatment options currently available.
This approach offers a novel experimental platform for probing human brain development and disease mechanisms that are otherwise difficult to study, providing a promising route for future investigations into neurodevelopmental disorders and potential therapies.